NYSE:BIO.B Bio-Rad Laboratories (BIO.B) Stock Price, News & Analysis $389.98 0.00 (0.00%) As of 11/12/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsNews and TrendsSEC Filings About Bio-Rad Laboratories Stock (NYSE:BIO.B) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Bio-Rad Laboratories alerts:Sign Up Key Stats Today's Range$389.98▼$389.9850-Day Range$364.15▼$389.9852-Week Range$244.54▼$389.98Volume73 shsAverage Volume33 shsMarket Capitalization$10.43 billionP/E Ratio10.27Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Bio-Rad Laboratories, Inc. develops and manufactures products for life science research and clinical diagnostics. Founded in 1952, the company serves research institutions, biotechnology and pharmaceutical companies, clinical laboratories, hospitals and other customers around the world. Its life science business supplies instruments, reagents and software used in areas such as gene expression, protein analysis, cell biology and genomics. Its offerings include PCR and digital PCR systems, electrophoresis products and tools for protein purification and analysis. Bio-Rad’s clinical diagnostics business provides testing systems, reagents and quality-control products for laboratories. Its products support areas including diabetes monitoring, infectious disease testing, blood typing and immunohematology. The company is headquartered in Hercules, California, and Norman Schwartz serves as its president and chief executive officer.AI Generated. May Contain Errors. Read More Receive BIO.B Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIO.B Stock News HeadlinesBio-Rad Laboratories Inc (BIO) (Q3 2026) Earnings Call Highlights: Return to Currency-Neutral ...November 5, 2026 | finance.yahoo.comBio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual ForumSeptember 16, 2026 | finance.yahoo.comUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This past May, flooding cut the supply route into the largest uranium complex on the planet, and in July Cigar Lake went down a second time. Gerardo Del Real calls this the Third Convergence Event and has backed three small companies positioned in front of it.November 13 at 1:00 AM | Digest Publishing (Ad)Bio Rad (BIO) Stock Could Be 23% Overvalued As Column Expansion ContinuesSeptember 15, 2026 | finance.yahoo.comBio-Rad Laboratories, Inc. Class BJuly 7, 2026 | cnn.comDisappointing results hurt Bio-Rad Laboratories, Inc. (BIO)March 20, 2026 | msn.comIs It Time To Reassess Bio-Rad Laboratories (BIO) After Multi Year Share Price WeaknessFebruary 15, 2026 | finance.yahoo.comBiodesix shares surge 10% on expanded Bio-Rad collaborationOctober 22, 2025 | msn.comSee More Headlines BIO.B Stock Analysis - Frequently Asked Questions How have BIO.B shares performed this year? Bio-Rad Laboratories' stock was trading at $310.70 at the beginning of the year. Since then, BIO.B shares have increased by 25.5% and is now trading at $389.98. How were Bio-Rad Laboratories' earnings last quarter? Bio-Rad Laboratories, Inc. (NYSE:BIO.B) released its quarterly earnings results on Wednesday, November, 4th. The company reported $2.65 EPS for the quarter. The company earned $656.40 million during the quarter. Bio-Rad Laboratories had a trailing twelve-month return on equity of 3.58% and a net margin of 39.45%. Does Bio-Rad Laboratories have any subsidiaries? Bio-Rad Laboratories subsidiaries include these companies: Celsee, Raindance Technologies Limited, GnuBIO Inc., Bio-Rad AbD Serotec GmbH, QuantaLife, DiaMed Holding AG, Blackhawk Biosystems, and more. How do I buy shares of Bio-Rad Laboratories? Shares of BIO.B stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/04/2026Today11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (5m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 BIO.B's financial health is in the Green zone, according to TradeSmith. BIO.B has been in this zone for over 5 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:BIO.B CIK12208 Webwww.bio-rad.com Phone510-724-7000Fax1-510-7415815Employees7,450Year Founded1952Profitability EPS (Trailing Twelve Months)$37.97 Trailing P/E Ratio10.27 Forward P/E RatioN/A P/E GrowthN/ANet Income$759.90 million Net Margins39.45% Pretax Margin50.92% Return on Equity3.58% Return on Assets2.51% Debt Debt-to-Equity Ratio0.11 Current Ratio3.18 Quick Ratio2.37 Sales & Book Value Annual Sales$2.58 billion Price / Sales4.04 Cash Flow$10.02 per share Price / Cash Flow38.91 Book Value$284.35 per share Price / Book1.37Miscellaneous Outstanding Shares26,740,000Free Float19,150,000Market Cap$10.43 billion OptionableNot Optionable Beta1.00 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NYSE:BIO.B) was last updated on 11/12/2026 by MarketBeat.com Staff. From Our PartnersTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | SponsoredURGENT: If you own a home, please review the map below.More than 1,300 red dots are scattered across the country, and 2,800 more are already on the way. Jim Rickards...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIO.B Stock Alerts